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CD9 is a membrane protein belonging to the tetraspanin family. Despite CD9’s broad tissue distribution, the only
abnormality observed in CD9-deficient mice was infertility of females, which was responsible for a defect in the sperm–egg
fusion process. However, the function of CD9 in sperm–egg fusion is not clear at all because the technique to analyze the
activity of molecules in sperm–egg fusion has not been established. We demonstrated that the exogenous mouse CD9,
expressed by polyadenylated mRNA injection at the germinal-vesicle stage oocytes, was precisely localized to the egg
plasma membrane, and the expression reversed the infertility of CD9/ eggs. Then, two other tetraspanins, human CD9 and
mouse CD81, overexpressed with this technique on CD9/ eggs restored the fertilization rate up to 90 and 50% against
that of wild type eggs, respectively. Moreover, in the presence of an anti-mouse CD9 mAb, which blocks sperm–egg fusion,
expression of human CD9 or mouse CD81 on eggs also rescued the fusibility. These results suggested that human CD9 plays
a crucial role in human fertilization, and mouse CD81 has the potential to compensate for CD9 function in sperm–egg
fusion. In addition, the polyadenylated mRNA injection is effective for molecular analysis of sperm–egg
fusion. © 2002 Elsevier Science (USA)
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CD9, a member of the tetraspanin family containing
more than 20 molecules, has 4 transmembrane domains
and 2 extracellular loops, which are characteristic of the
family. CD9 and the members were reported to associate
with various types of membrane proteins, including inte-
grins, immunoglobulin superfamily proteins, and each
other, and postulated to participate in cell motility, adhe-
sion, proliferation, metastasis, viral infection, and cell fu-
sion (Boucheix and Rubinstein, 2001). Despite the broad
tissue distribution and the postulated various functions, the
only abnormality observed in CD9-deficient mice was in-
fertility of females, which was responsible for a defect in
the sperm–egg fusion process (Le Naour et al., 2000;
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All rights reserved.Miyado et al., 2000; Kaji et al., 2000). In wild-type eggs,
CD9 is abundantly expressed and localized on the mi-
crovilli, and an anti-mouse CD9 mAb blocks in vitro
fertilization (Chen et al., 1999). CD9 is associated with the
61 integrin in eggs, which was reported to be an important
molecule for fertilization (Miyado et al., 2000; Almeida et
al., 1995). However, Miller et al. (2000) showed that the
61 integrin was not essential for sperm–egg fusion,
proven with 6 integrin null eggs, and thus there are no
molecules, other than CD9, which are clearly demonstrated
to participate in sperm–egg fusion. To clarify the molecular
mechanism of sperm–egg fusion, a technique for directly
analyzing the activity of molecules in sperm–egg fusion is
required, the functional domain of CD9 needs to be deter-
mined, and the activity of other molecules associated with
CD9 must be investigated. In mammalian eggs, transcrip-
tion ceases on meiotic maturation, and translation is re-
duced, except for mRNAs polyadenylated in the cytoplasm
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such as cyclin B1 (Seydoux, 1996; Tay et al., 2000). How-
ever, by injection of the mRNAs with a long poly(A) tail
(200–400 A) into the oocytes at the germinal vesicle (GV)
stage, some exogenous proteins were expressed without
disturbing oocyte maturation and fertilizability in vitro,
although the technique was used only for research of
maturation or activation of eggs (Vassalli et al., 1989;
Williams et al., 1992; Aida et al., 2001). In this paper, with
this technique, we show that exogenous membrane pro-
teins are abundantly expressed and precisely localized to
egg plasma membrane, and we directly demonstrate that
mouse CD9, human CD9, and mouse CD81 expressed on
eggs from CD9-deficient mice reverse their infertility.
These results demonstrate that this technique is effective
for analyzing the molecules expected to participate in the
sperm–egg fusion process.
MATERIALS AND METHODS
Plasmid Construction
The full-length cDNAs encoding mouse CD9 and CD81, kindly
provided by Drs. M. Okazaki and H. Fujiwara, were each inserted
into cloning vectors, pBluescript SK (Stratagene) and pPICT3,
that have T7 and SP6 transcription initiation sites. Human CD9
cDNA was amplified from a human 293T cell total RNA by reverse
transcription (RT)–polymerase chain reaction (PCR) and cloned
into pGEM-T Easy Vector (Promega). The cDNA was sequenced to
confirm fidelity.
Preparation of Transcripts and Polyadenylation
mRNAs for mouse CD9 and CD81 and human CD9 were
synthesized and polyadenylated as described in Aida et al. (2001).
Briefly, the plasmids were linearized with restriction enzymes at
the 3 ends of these cDNAs, and mRNAs were synthesized by using
the T7 or SP6 MessageMachine Kit (Ambion). The transcripts were
polyadenylated by incubation for 1 h at 37°C in the presence of 100
M/liter ATP and 30 IU/ml poly(A) polymerase (Gibco) in a buffer
containing 250 mM NaCl, 50 mM Tris–HCl (pH 8.1), 10 mM
MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 1000 IU/ml RNasin
(Takara), and 0.05% BSA. To remove unincorporated ATP, the
polyadenylated mRNAs were purified with an RNeasy Kit (QIA-
GEN) according to the manufacturer’s directions, and dissolved in
RNase-free distilled water. The polyadenylation, estimated to be
200 A, was confirmed by agarose gel electrophoresis.
Oocyte Collection and Injection of RNA
CD9 homozygous deficient (CD9/) and heterozygous (CD9/)
oocytes at the GV stage were obtained from 8- to 10-week-old mice,
backcrossed with C57BL/6 mice for five generations. The geno-
types of such mice were assessed by RT-PCR using primers
KTP897 (5-ACGACGGGCGTTCCTTGCGCAGCTGTG-3) and
KTP898 (5-TCAGAAGAACTCGTCAAGAAGGCGATA-3), which
amplify the targeted locus, and KTP899 (5-CCTGATCGTAAAC-
CAGAGTC-3) and KTP900 (5-GGACACTGGAAGAGTTCATG-
3), which amplify the wild-type locus. Wild-type (CD9/) oocytes
at the GV stage were obtained from C57BL/6 mice for controls. To
block fertilization with the anti-CD9 mAb treatment, oocytes were
collected from 8- to 10-week-old ICR mice.
Immature oocytes at the GV stage were collected in M2 medium
supplemented with BSA (4 mg/ml). Oocytes with cumulus cells
only partially attached were selected and inserted with a micropi-
pette for injection with 5–10 pl of poly(A)–RNA solution (300–400
ng/l). After washing, the RNA-injected oocytes were transferred
into M16 medium supplied with 5% fetal bovine serum, and
cultured for 15–18 h at 37°C under 5% CO2 in air. In Fig. 1, oocytes
were collected and cultured for 3 h after injection in the presence of
100 mM 3-isobutyl-1-methlxanthine (IBMX) (Sigma).
In Vitro Fertilization
Mature eggs with a first polar body (PB1) were selected and freed
from the zona pellucida by pipetting in acidic Tyrode’s solution
following several minutes of incubation in 0.001% chymotrypsin
as described in Aida et al. (2001). Only the eggs that lost PB1 in this
process were used to distinguish eggs with the second polar body
after insemination. Spermatozoa obtained from the caudae epididy-
mides of B6D2F1 male mice (11- to 15-week-old) were incubated in
M16 medium supplemented with BSA (4 mg/ml) for more than 15 h
at 37°C under 5% CO2 in air. Eggs were inseminated by adding a
small amount of the sperm suspension to the egg-containing
medium. After coincubation with sperm for 2 h, eggs were washed
by pipetting and fixed with 4% paraformaldehyde in PBS for 10
min. Chromosomes of eggs and sperm were stained with Hoechst
33342 to score the fertilization rates.
Immunohistochemistry and Imaging
Mouse CD9 on fixed eggs was reacted with a rat anti-mouse CD9
mAb, KMC8, or a biotinylated KMC8 (Pharmingen), followed by
FITC-conjugated goat anti-rat IgG polyclonal antibodies (Cappel) or
Cy3-conjugated avidin (Jackson Laboratory), respectively. Human
CD9 and mouse CD81 were visualized with a mouse anti-human
CD9 mAb, ALB6 (Cymbus Bio.) and a hamster anti-mouse CD81
mAb, EAT-1 (Pharmingen), followed by Cy3-conjugated donkey
anti-mouse IgG polyclonal antibodies (Jackson Laboratory) and a
FITC-conjugated mouse anti-hamster IgG mAb (Pharmingen), re-
spectively. For observation of the egg surface, eggs were mounted
by using the ProLong Antifade Kit (Molecular Probes). Images were
captured with the Micro Max System compound Olympus fluores-
cence microscope. Nomarski (DIC) optics were used on all bright-
light images. Overlays of captured images were processed with
Adobe Photoshop 6.0.
RESULTS
Expression of CD9–EGFP Fusion Protein on Eggs
by Poly(A) RNA Injection
We first tested whether a polyadenylated mRNA encod-
ing a mouse CD9–EGFP fusion protein [mCD9—EGFP–
poly(A) RNA], which was injected into oocytes at the GV
stage, was translated and the resulting protein was localized
to the plasma membrane. The polyadenylated mRNAs were
injected into oocytes in the presence of IBMX, which
maintain oocytes at the GV stage and give a longer time for
RNA translation before maturation (Williams et al., 1992).
As shown in Fig. 1, the mouse CD9–EGFP fusion protein
(mCD9–EGFP) was observed in the cytoplasm 2–3 h after
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injection, and then it began to localize to the plasma
membrane about 6 h after injection. The localization was
cleared after incubation for 18 h, and normal maturation of
oocytes expressing mCD9-EGFP was observed after re-
moval of IBMX. Because the high expression of exogenous
protein was performed with or without IBMX as described
by Aida et al. (2001), IBMX was not used in subsequent
experiments.
Recovery from Infertility of CD9-Deficient Eggs by
Poly(A) RNA Injection
CD9 homozygous deficient (CD9/) and heterozygous
(CD9/) mice were previously generated (Kaji et al., 2000)
and were backcrossed with C57BL/6 mice for five genera-
tions. To determine whether the exogenous mCD9 ex-
pressed with this technique is functional, rescue experi-
ments were performed by using oocytes from CD9/
female mice (CD9/ oocytes) (Fig. 2). CD9/ oocytes at the
GV stage, into which mCD9–poly(A) RNAs were injected,
were matured in vitro, and the mature eggs were insemi-
nated after removal of the zona pellucida. Control oocytes
were prepared from CD9/, CD9/, and CD9/ mice with
no RNA injection. After coincubation with sperm for 2 h, eggs
were fixed and stained with Hoechst 33342, a cell-permeant
fluorescent DNA probe, and we determined the fertilization
rate by counting the number of eggs released from meta-
phase II arrest, as a result of sperm–egg fusion. Aside from
that, to judge whether the eggs were fertilized compara-
tively early or late after insemination, we divided fertilized
eggs into two groups: eggs with the second polar body (PB2)
(the percentages are shown in the black of columns in Fig.
2A) and eggs at anaphase in which eggs did not have PB2 yet
(the percentages are shown in the gray). The fertilization
rate (shown in the black plus the gray in the column) of the
CD9/ eggs with mCD9–poly(A) RNA injection was re-
stored up to 76%, while that of CD9/ eggs with no RNA
injection was only 3% (Fig. 2A). This result suggested that
FIG. 1. Expression of CD9–EGFP on the oocytes with polyadenylated RNA injection. Immature oocytes at the GV stage were injected
with CD9–EGFP RNA harboring a poly(A) tail, and cultured in the presence of 100 mM IBMX. After 3 h, oocytes were washed and cultured
in the absence of IBMX to allow for meiotic maturation. Chromosomes stained with Hoechst 33342 (blue) and CD9–EGFP (green) were
observed by fluorescence microscopy at the indicated time. Bottom panels show superimposed images of each upper panel. The oocyte
diameter is 70 m. In addition to a strong signal of the surface fluorescence, a weaker signal of the intracellular fluorescence is observed
in all eggs injected with mCD9–EGFP mRNA. The data shown are representative of all experiments.
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mCD9 expressed by RNA injection is sufficiently func-
tional, and this technique is useful to investigate whether
other molecules can compensate for the function of mouse
CD9 in sperm–egg fusion. Moreover, we found that the
fertilization rate of CD9/ eggs was 61%, though CD9/
female mice breed similarly to CD9/ female mice (Miyado
et al., 2000; our unpublished data). The expression level of
CD9 was also examined by indirect immunofluorescence.
As shown in Fig. 2B, CD9/ eggs with mCD9–poly(A) RNA
injection (Fig. 2B, / mCD9) exhibited strong expres-
sion of CD9, the same as CD9/ eggs (Fig. 2B, /),
whereas the expression in CD9/ eggs (Fig. 2B, /) was
weaker than that in CD9/ eggs. These results suggest that
the fertilization rate in vitro correlates with the expression
level of CD9.
Functional Compensation for Mouse CD9 by
Human CD9 or Mouse CD81
We investigated whether two other tetraspanins, human
CD9 (hCD9) and mouse CD81 (mCD81), can compensate
for the function of mouse CD9. The amino acid sequence of
hCD9 has about 90% homology to mCD9, but in human,
the function of hCD9 in sperm–egg fusion has not yet been
reported. While mCD81 is a molecule harboring about 47%
homology to mCD9, its role in myoblast fusion together
with mCD9 has been reported (Tachibana and Hemler,
1999). Moreover, expression of mCD81 on eggs and only
small inhibition of sperm–egg fusion by anti-CD81 mAb
have been reported (Takahashi et al., 2001). As shown in
Figs. 3A and 3B, the fertilization rate of CD9/ eggs with
polyadenylated hCD9 mRNA [hCD9–poly(A) RNA] injec-
tion or mCD81 mRNA [mCD81–poly(A) RNA] injection
was 81 or 47%. Strong expression of hCD9 or mCD81 on
CD9/ eggs with RNA injection was observed at a level
similar to that of endogenous mCD9 on CD9/ eggs (Figs.
3C, / hCD9, red; and Fig. 3D, / mCD81, green).
The expression of endogenous mCD81 on eggs was slightly
detected with an anti-mCD81 mAb, EAT-1, or EAT-2, but
this signal could not be captured well during the proper
exposure time (Fig. 3D, lower left, / and /). These
staining results were consistent with the data of RNA
expressions obtained from RT-PCR of mouse oocytes at the
GV stage (date not shown) and with the report in which the
high expression of CD9 but not of CD81 was detected in a
serial analysis of gene expression (SAGE) in the human
oocyte (Neilson et al., 2000). Overexpressed hCD9 and
mCD81 molecules seemed to be localized on the egg
microvilli, which surrounded the sperm head before fusion,
like endogenous mCD9 in wild type eggs as previously
reported (Figs. 3E and 3F, arrows) (Kaji et al., 2000). These
results suggest that hCD9 and mCD81 can function like
mCD9 in mouse sperm–egg fusion, although in the case of
mCD81, the endogenous expression level is much lower
than that of mCD9, and the activity is also lower than that
of mouse or human CD9.
Recovery from Anti-mouse CD9 mAb-Induced
Infertility by Expression of Human CD9 or Mouse
CD81
As well as the infertility of CD9/ eggs, the blocking of
sperm–egg fusion by the anti-mCD9 mAb KMC8 in vitro
has been reported (Chen et al., 1999; Miller et al., 2000).
Thus, we examined whether this block can be reversed by
FIG. 2. Recovery of the fertilization rate of CD9/ eggs by mouse
CD9–poly(A) RNA injection. CD9/, CD9/, and CD9/ oocytes
at the GV stage without RNA injection (/, /, /) and
CD9/ oocytes at the GV stage with mCD9–poly(A) RNA injec-
tion (/ mCD9) were matured in vitro as described under
Materials and Methods. The mature eggs, from which zona pellu-
cida were removed, were coincubated with sperm for 2 h. (A) The
fertilization rate. The numbers of fertilized eggs in total oocytes are
noted above each column. The percentages of eggs at anaphase and
eggs with second polar body are shown in gray and black, respec-
tively. Experiments were done three times with more than six eggs
in each group. (B) Expression of mouse CD9. Mouse CD9 (green)
was stained with the anti-mouse CD9 mAb, KMC8. Each egg
represents all CD9/, CD9/, CD9/, and CD9/ mCD9 eggs
used in these experiments. The lower left panel shows superim-
posed images of each panel. The egg diameter is 70 m.
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FIG. 3. Recovery of fertilization rate of CD9/ eggs by overexpression of human CD9 or mouse CD81. CD9/ and CD9/ eggs as well
as CD9/ eggs expressing human CD9 or mouse CD81 were obtained as described under Materials and Methods. After removal of zona
pellucida, eggs were coincubated with sperm for 2 h. The fertilization rates of eggs overexpressing human CD9 (A) and mouse CD81 (B).
The numbers of fertilized eggs in total eggs are noted above each column. The percentages of eggs at anaphase and of eggs with second polar
body are shown in gray and black, respectively. Experiments were done three times with more than five eggs in each group. Expression of
human CD9 (C) and mouse CD81 (D). In (C), mouse CD9 (green) and human CD9 (red) were stained with the rat anti-mCD9 mAb and the
mouse anti-hCD9 mAb, followed by FITC-conjugated anti-rat IgG and Cy3-conjugated anti-mouse IgG polyclonal antibodies, respectively.
In (D), mouse CD9 (red) and mouse CD81 (green) were stained with the biotinylated anti-mCD9 mAb and the hamster anti-mCD81 mAb,
followed by Cy3-conjugated avidin and an FITC-conjugated anti-hamster IgG mAb, respectively. (E, F) Localization of overexpressed human
CD9 and mouse CD81 on the egg microvilli. Expression of human CD9 (E, red) and mouse CD81 (F, green) on the surfaces of eggs was
observed after mounting with the ProLong Antifade Kit. Chromosomes of sperm (blue) were stained with Hoechst 33342. The right panels
are magnified images of the white square regions in the left. Human CD9 and mouse CD81 were localized surrounding the spermhead
(arrows). The staining data shown are representative of all experiments.
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overexpression of hCD9 or mCD81. As shown in Figs. 4A
and 4B, in the presence of 50 g/ml KMC8, zona-free eggs
hardly fertilized, but the fertilization rates of eggs with
hCD9 and mCD81–poly(A) RNA injection were restored to
78 and 75%, respectively. These results indicate that over-
expression of hCD9 and mCD81 can rescue the fusibility
blocked by the anti-CD9 mAb. Moreover, for the percent-
ages of fertilized eggs with PB2 (black), the restored rates
against that of control eggs, inseminated in the absence of
an anti-mCD9 mAb, were 93 (hCD9) and 64% (mCD81),
respectively (Figs. 4A and 4B). The eggs with the second
polar body 2 h after insemination are considered to be eggs
fertilized within 1 h after insemination because it takes
more than 1 h from the time of sperm–egg fusion to
completion of the second polar body formation. Therefore,
in the rescue of fusibility blocked by an anti-mCD9 mAb,
the activity of mCD81 was lower than that of hCD9 in
accord with the results in Fig. 3. After insemination, eggs
with hCD9- or mCD81–poly(A) RNA injection were stained
with the corresponding antibodies, and the high levels of
expression of exogenous proteins were detected (data not
shown). As shown in Figs. 4C and 4D, overexpressed hCD9
and mCD81 molecules were colocalized with endogenous
mCD9, which is possibly localized mainly in the microvilli
(Kaji et al., 2000), and they surrounded the sperm heads
(shown by arrows).
DISCUSSION
In this report, we show that the exogenous mouse CD9
was abundantly expressed on egg plasma membrane by
FIG. 4. Recovery of fertilization rate by expression of human CD9 or mouse CD81 in the presence of anti-mouse CD9 mAb, KMC8.
Zona-free normal eggs and eggs overexpressing human CD9 and mouse CD81 were cultured for 30 min in the presence or absence of 50
g/ml anti-CD9 mAb, KMC8, and then inseminated by adding the sperm to the culture medium. The fertilization rates of eggs
overexpressing human CD9 (A) and mouse CD81 (B). The numbers of fertilized eggs in total eggs are noted above each column. The
percentages of eggs at anaphase and that of eggs with second polar body are shown in gray and black, respectively. Experiments were done
four (A) or three (B) times with more than seven eggs in each group. (C, D) Localization of human CD9 and mouse CD81 together with
mouse CD9 on the egg microvilli. After insemination in the presence of anti-CD9 mAb, eggs overexpressing human CD9 and mouse CD81
were stained with the anti-mouse CD9 mAb (green) and the anti-human CD9 mAb (red) (C), or anti-mouse CD9 mAb (red) and the
anti-mouse CD81 mAb (green) (D), and the surfaces were observed. Chromosomes of sperm (blue) were stained with Hoechst 33342. The
right panel shows superimposed images of the three panels on the left. Human CD9 and mouse CD81 were colocalized with endogenous
mouse CD9 surrounding the spermhead (arrows). The staining data shown are representative of all experiments.
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poly(A)–RNA injection and the exogenous CD9 reversed
the infertility of CD9/ eggs. Therefore, this technique
could be effective for analyzing the functional domain of
CD9 and the function of other molecules expected to be
associated with CD9 for participation in sperm–egg fusion.
Unexpectedly, as shown in Fig. 2, the fertilization rate of
CD9/ eggs was lower than that of CD9/ eggs, correspon-
dent with the lower expression level of CD9, despite the
normal number of pups born to a CD9/ female mouse; the
contradiction between in vitro and in vivo fertilization may
the result of the different interaction times between eggs
and sperm. In fact, even in CD9/ eggs, the fertilization
rate was increased in vitro when the coincubation time
with sperm was longer (Miyado et al., 2000; Kaji et al.,
2000). In this report, human CD9 compensated for the
function of mouse CD9 at a high level in CD9/ eggs. This
is the first finding to suggest the contribution of hCD9 to
human fertilization, and the research into human contra-
ception that might be performed with mouse eggs using our
method is very interesting. The fact that mCD81 can
compensate for the function of mCD9 is also remarkable,
though both the activity and the endogenous expression
level on eggs were lower than those of mouse CD9. This
result first directly suggests that tetraspanins can function-
ally substitute each other, and, in CD9-deficient mice, the
substitution by other tetraspanin(s) may cause no abnor-
malities except female sterility. Moreover, although the
inhibitory mechanism of fertilization by anti-mCD9 mAb
is not clear, the antibody treatment did not make the eggs
infertile, but the inhibition may be due to blocking against
the interaction between mCD9 and other molecule(s), be-
cause the inhibition was overcome by overexpression of
human CD9 and mouse CD81
Although the amounts of different molecules expressed
by RNA injection are not comparable with each other
strictly because they were visualized only by staining with
proper antibodies, our results suggest that human CD9 and
mouse CD81 can compensate for the function of mouse
CD9 in sperm–egg fusion. The function of human CD9 and
monkey CD9 as a coreceptor of diphtheria toxin and that of
human CD81 as a receptor of Hepatitis C virus are not
replaced by other tetraspanins (Nakamura et al., 2000;
Pileri et al., 1998). These functions are strictly determined
by the two or three amino acid residues between the
conserved CCG motif and the fourth cysteine residue of the
large extracellular loop domain (Hasuwa et al., 2001; Hig-
ginbottom et al., 2000). There are only five matches in
amino acid residues between mCD9 and mCD81 in the
region I152–P178 of mCD9; thus the functional replace-
ment of CD9 with mCD81 in sperm–egg fusion may be
determined by the three-dimensional structure of the mol-
ecules. The function and functional domain(s) of CD9 in
sperm–egg fusion remain unclear, but in further experi-
ments, the technique developed in this work may be a
powerful tool with which to reveal not only the role of CD9
but also the other molecular mechanism in sperm–egg
fusion.
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